Moderna’s New Vaccine is More Protective Against Flu Than Existing Vaccine, Study Shows
Moderna’s flu vaccine candidate performed well in a phase 3 clinical trial, the company announced. In a Compared to an already-approved flu vaccine, Moderna’s mRNA-1010 flu vaccine was almost 27 percent more effective at preventing disease in people age 50 and older. The vaccine candidate demonstrate strong results for all strains targeted by the shot. The study found no differences in efficacy between age groups, flu vaccination status individuals with a variety of risk factors.
As Diseases of The Past Make a Comeback, Doctors and Med Schools Work to Find an Answer
“Diseases of the past” like measles have returned in a big way. Many doctors are having to learn or re-learn how to diagnose and treat these infections. At Rush University Medical Center, medical students are now learning with the help of AI tools how to more swiftly identify measles rashes on various skin tones. Falling vaccination rates have allowed diseases like chicken pox, invasive strep pneumoniae and pertussis to thrive as well, reversing years of progress.
“You’re taught these things in medical school, and you’re taught from a very academic perspective with the sense of measles was eradicated in 2000,” said Nicholas Cozzi, EMS Medical Director at Rush. “Now we’re having a resurgence, the highest in 25 years, and you might have not reviewed that since the first year of medical school…It’s a new paradigm and a new normal that we have to adapt to.”
Full Story: Axios,
